These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Classification of Parkinsonian syndromes from FDG-PET brain data using decision trees with SSM/PCA features. Mudali D; Teune LK; Renken RJ; Leenders KL; Roerdink JB Comput Math Methods Med; 2015; 2015():136921. PubMed ID: 25918550 [TBL] [Abstract][Full Text] [Related]
5. Abnormal metabolic brain network associated with Parkinson's disease: replication on a new European sample. Tomše P; Jensterle L; Grmek M; Zaletel K; Pirtošek Z; Dhawan V; Peng S; Eidelberg D; Ma Y; Trošt M Neuroradiology; 2017 May; 59(5):507-515. PubMed ID: 28386687 [TBL] [Abstract][Full Text] [Related]
6. Parkinson's disease-related perfusion and glucose metabolic brain patterns identified with PCASL-MRI and FDG-PET imaging. Teune LK; Renken RJ; de Jong BM; Willemsen AT; van Osch MJ; Roerdink JB; Dierckx RA; Leenders KL Neuroimage Clin; 2014; 5():240-4. PubMed ID: 25068113 [TBL] [Abstract][Full Text] [Related]
7. Spectral guided sparse inverse covariance estimation of metabolic networks in Parkinson's disease. Spetsieris PG; Eidelberg D Neuroimage; 2021 Feb; 226():117568. PubMed ID: 33246128 [TBL] [Abstract][Full Text] [Related]
8. Scaled Subprofile Modeling and Convolutional Neural Networks for the Identification of Parkinson's Disease in 3D Nuclear Imaging Data. Manzanera OM; Meles SK; Leenders KL; Renken RJ; Pagani M; Arnaldi D; Nobili F; Obeso J; Oroz MR; Morbelli S; Maurits NM Int J Neural Syst; 2019 Nov; 29(9):1950010. PubMed ID: 31046514 [TBL] [Abstract][Full Text] [Related]
9. FDG PET Parkinson's disease-related pattern as a biomarker for clinical trials in early stage disease. Matthews DC; Lerman H; Lukic A; Andrews RD; Mirelman A; Wernick MN; Giladi N; Strother SC; Evans KC; Cedarbaum JM; Even-Sapir E Neuroimage Clin; 2018; 20():572-579. PubMed ID: 30186761 [TBL] [Abstract][Full Text] [Related]
10. Characterization of disease-related covariance topographies with SSMPCA toolbox: effects of spatial normalization and PET scanners. Peng S; Ma Y; Spetsieris PG; Mattis P; Feigin A; Dhawan V; Eidelberg D Hum Brain Mapp; 2014 May; 35(5):1801-14. PubMed ID: 23671030 [TBL] [Abstract][Full Text] [Related]
11. Data-driven, voxel-based analysis of brain PET images: Application of PCA and LASSO methods to visualize and quantify patterns of neurodegeneration. Klyuzhin IS; Fu JF; Hong A; Sacheli M; Shenkov N; Matarazzo M; Rahmim A; Stoessl AJ; Sossi V PLoS One; 2018; 13(11):e0206607. PubMed ID: 30395576 [TBL] [Abstract][Full Text] [Related]
12. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of brain MRI and 18F-FDG PET in the differentiation of Parkinsonian-type multiple system atrophy from Parkinson's disease. Kwon KY; Choi CG; Kim JS; Lee MC; Chung SJ Eur J Neurol; 2008 Oct; 15(10):1043-9. PubMed ID: 18717730 [TBL] [Abstract][Full Text] [Related]
14. Integrative analysis of blood metabolomics and PET brain neuroimaging data for Parkinson's disease. Glaab E; Trezzi JP; Greuel A; Jäger C; Hodak Z; Drzezga A; Timmermann L; Tittgemeyer M; Diederich NJ; Eggers C Neurobiol Dis; 2019 Apr; 124():555-562. PubMed ID: 30639291 [TBL] [Abstract][Full Text] [Related]
15. Machine learning identified an Alzheimer's disease-related FDG-PET pattern which is also expressed in Lewy body dementia and Parkinson's disease dementia. Katako A; Shelton P; Goertzen AL; Levin D; Bybel B; Aljuaid M; Yoon HJ; Kang DY; Kim SM; Lee CS; Ko JH Sci Rep; 2018 Sep; 8(1):13236. PubMed ID: 30185806 [TBL] [Abstract][Full Text] [Related]
16. Use of deep learning-based radiomics to differentiate Parkinson's disease patients from normal controls: a study based on [ Sun X; Ge J; Li L; Zhang Q; Lin W; Chen Y; Wu P; Yang L; Zuo C; Jiang J Eur Radiol; 2022 Nov; 32(11):8008-8018. PubMed ID: 35674825 [TBL] [Abstract][Full Text] [Related]
17. Identification of disease-related spatial covariance patterns using neuroimaging data. Spetsieris P; Ma Y; Peng S; Ko JH; Dhawan V; Tang CC; Eidelberg D J Vis Exp; 2013 Jun; (76):. PubMed ID: 23851955 [TBL] [Abstract][Full Text] [Related]
18. Cognitive signature of brain FDG PET based on deep learning: domain transfer from Alzheimer's disease to Parkinson's disease. Choi H; Kim YK; Yoon EJ; Lee JY; Lee DS; Eur J Nucl Med Mol Imaging; 2020 Feb; 47(2):403-412. PubMed ID: 31768599 [TBL] [Abstract][Full Text] [Related]
19. Scaled subprofile modeling of resting state imaging data in Parkinson's disease: methodological issues. Spetsieris PG; Eidelberg D Neuroimage; 2011 Feb; 54(4):2899-914. PubMed ID: 20969965 [TBL] [Abstract][Full Text] [Related]
20. Corticostriatal covariance patterns of 6-[18F]fluoro-L-dopa and [18F]fluorodeoxyglucose PET in Parkinson's disease. Kaasinen V; Maguire RP; Hundemer HP; Leenders KL J Neurol; 2006 Mar; 253(3):340-8. PubMed ID: 16222426 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]